Clinical Trial Update: Bevacizumab and Endothelium Dependent Vasodilation [NA]

View source ↗

Summary

Bevacizumab trial focusing on endothelium-dependent vasodilation has completed, with Radboud University Medical Center as sponsor and conditions including hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Endothelial Dysfunction
• Hypertension

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Hypertension, Cancer | NA | Status: COMPLETED